The ratio of human glandular kallikrein (hK2) to free PSA improves the discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately elevated total PSA levels

被引：0
|
作者：
Magklara, A
Scorilas, A
Catalona, WJ
Diamandis, EP
机构：
[1] Washington Univ, Sch Med, Dept Surg, Div Urol Surg, St Louis, MO 63110 USA
[2] Univ Toronto, Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada
来源：
CLINICAL CANCER RESEARCH | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
483
引用
收藏
页码：3826S / 3827S
页数：2
相关论文
共 50 条
  • [21] Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues
    Olsson, AY
    Bjartell, A
    Liija, H
    Lundwall, A
    INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (02) : 290 - 297
  • [22] Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines
    Magklara, A
    Grass, L
    Diamandis, EP
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 59 (03) : 263 - 270
  • [23] Rates of change in levels of HK2, free and total PSA up to 20 years before diagnosis of prostate cancer
    Ulmert, D
    Becker, C
    Bjork, T
    Malmo, JA
    Berglund, G
    Lilja, H
    JOURNAL OF UROLOGY, 2003, 169 (04): : 384 - 384
  • [24] Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines
    Angeliki Magklara
    Linda Grass
    Eleftherios P. Diamandis
    Breast Cancer Research and Treatment, 2000, 59 : 263 - 270
  • [25] Discrimination between benign prostatic hyperplasia and prostate cancer by means of PSA index in urology outpatient consult
    Pinedo-Pichilingue, Aranza
    San Martin-San Martin, Gustavo
    Yhuri Carreazo, Nilton
    REVISTA INTERNACIONAL DE ANDROLOGIA, 2016, 14 (01): : 13 - 18
  • [26] Serum levels of prostate specific antigen, free PSA, [-2]proPSA, fPSA/tPSA ratio, Prostate Health Index, and glycosylation patterns of free PSA in patients with benign prostatic hyperplasia pharmacotherapy
    Jirasko, Michal
    Vitak, Roman
    Pecen, Ladislav
    Pinkeova, Andrea
    Tkac, Jan
    Bertok, Tomas
    Bergman, Natalie
    Kucera, Radek
    PROSTATE, 2024,
  • [27] Early detection of prostate cancer in African American men through use of multiple biomarkers: Human kallikrein 2 (hK2), prostate specific antigen (PSA) and free PSA (FPSA).
    Finlay, JA
    Jacinto, JM
    Sterling, K
    Pollard, S
    Lifsey, D
    Rayford, W
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1197S - 1198S
  • [28] The proportion of prostate-specific antigen (PSA) complexed to α1-antichymotrypsin improves the discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA of 10 to 30 μg/L
    Martínez, M
    España, F
    Royo, M
    Alapont, JM
    Navarro, S
    Estellés, A
    Aznar, J
    Vera, CD
    Jiménez-Cruz, JF
    CLINICAL CHEMISTRY, 2002, 48 (08) : 1251 - 1256
  • [29] Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer marker
    Darson, MF
    Pacelli, A
    Roche, P
    Rittenhouse, HG
    Wolfert, RL
    Young, CYF
    Klee, GG
    Tindall, DJ
    Bostwick, DG
    UROLOGY, 1997, 49 (06) : 857 - 862
  • [30] Prostate-specific antigen (hK3) and human prostatic glandular kallikrein (hK2) in the detection of early stage human prostate cancer
    Wilson, MJ
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 131 (04): : 298 - 299
12345